Gastrointestinal Involvement

Resources

• Treatment Options for Pulmonary Arterial Hypertension (This information has been provided courtesy of the Pulmonary Hypertension Association.)
• Frequently Asked Questions. (This information has been provided courtesy of the Pulmonary Hypertension Association.)

Articles

• "New Medicines Can Help Lower High Blood Pressure in Lungs," by Paul G. Donohue, M.D. "To Your Good Health," January 20, 2008
• "What's Up Doc?" (originally published in "Scleroderma VOICE," March 2007)
  Question: "What are the current treatments for pulmonary fibrosis
  associated with scleroderma, and does Revatio help?" Answer...
• "Epoprostenol Treatment Effective in Children With Severe Pulmonary Hypertension," Medscape online, June 11, 2006
• "Evaluating the Lung in Connective Tissue Disease," response from Joseph C. Shanahan, M.D., Assistant Professor, Rheumatology and Immunology; Clinical Director, Duke Scleroderma Research Center; Associate Director, Duke Lupus Clinic, Duke University Medical Center, Durham, North Carolina , originally published on "Medscape Today" Web site, April 24, 2007. Requires free login and password.
• "PAH in Connective Tissue Disease," by Christian M. Kahler, M.D., originally published in "Rheumatology News," Volume 6, Issue 4, Page 8 (April 2007)
• "Pulmonary Hypertension in Patients With Interstitial Lung Diseases," by Ryu, Jay H; Krowka, Michael J; Pellikka, Patricia A; Swanson, Karen L; McGoon, Michael D. Originally published on redorbit.com, April 13, 2007. Note: This is a technical article intended for health professionals. But laypersons can also gain benefit from reviewing this.
• "Sildenafil Increases Walk Distance in Pulmonary Fibrosis Patients," originally published on "Medscape Today" Web site, March 12, 2007. Requires free login and password.
• "Lung CT Densitometry Correlates With Lung Function, Exercise in Systemic Sclerosis", originally published on "Medscape Today" Web site, March 30, 2007. Requires free login and password.
• Is Pulmonary Arterial Hypertension Ever Reversible?," Response from Steven D. Nathan, M.D., Medical Director, Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, originally published on "Medscape Today" Web site, March 9, 2007. Requires free login and password.
• "Complications Associated with Pulmonary Arterial Hypertension," Response from Myung H. Park, M.D., FACC, Assistant Professor of Medicine; Director, Pulmonary Vascular Diseases Program, University of Maryland Medical Center, Baltimore, Maryland, originally published on "Medscape Today" Web site, February 20, 2007
• "Scleroderma, Systemic Lupus Erythematosus, and Pulmonary Arterial Hypertension," by Joseph Shanahan, M.D., January 25, 2007
• "Early Diagnosis of PAH in Systemic Sclerosis: How Do We Recognize the Warning Signs?" by Joseph C. Shanahan, M.D., January 17, 2007
• "Treatment Targets for PAH in Systemic Sclerosis," by Myung H. Park, M.D., FACC, January 17, 2007
• "Management of Interstitial (ILD) and Fibrotic Lung Disease," approved by Kevin Brown, M.D., originally published by the National Jewish Medical and Research Center, January 2005
• "New Treatment Hope for Systemic Sclerosis," by Frank A. Wollheim, "Arthritis & Rheumatism," January 2007; (DOI: 10.1002/art.22315).
• "Pulmonary Fibrosis in Systemic Sclerosis," by Kevin Brown, M.D., "Rheumatology News," Volume 5, Issue 12, Page 22 (December 2006)
• Exercise Improves Quality of Life in Pulmonary Hypertension Patients, September 19, 2006
• Pulmonary Arterial Hypertension in Scleroderma," by Ioana Preston, M.D. (originally published in "Scleroderma Voice," 2006 #1)
• Study Shows Inhaled Medicine Improves Survival for Lung Transplant Patients, University of Maryland Medical Center News Release, January 11, 2006
• "Bosentan Ups Survival of Patients With Scleroderma-Associated PAH," by Bruce Jancin (Denver Bureau), "Rheumatology News," Volume 5, Issue 1, Page 14 (January 2006)
• Sitaxsentan (Thelin™) Becomes the First Agent to Show Efficacy Against PAH-CTD. Used with permission from Pinpoint Limited, "Cardiology News, " Dec./Jan. issue.
• Cytoxan Offers Modest Sclerosis Lung Benefits: The first RCT assessing the drug for interstitial lung disease showed a slowing in functional decline, Sept. 2005
• Actelion Ltd.: JACC Publication on Tracleer in Children with PAH, August 2005
• FDA MedWatch – Cialis (Tadalafil), Levitra (Vardenafil hydrochlor ide), Viagra (Sildenafil citrate): Reports of sudden vision loss, July 2005
• FDA Approves Pfizer's Revatio as Treatment for Pulmonary Arterial Hypertension, June 2005
• "Breathing life into PAH treatments," originally published in "Script" magazine, May 2005. You will need Adobe Acrobat Reader to download this file. If you do not have it, download it free now!
• "Drug alleviates scleroderma; Disease of lungs and connective tissues responds to anti-cancer medication," by Thomas H. Maugh II, "Los Angeles Times, May 2005 ".
• "Cancer Drug Helps Scleroderma Patients," May 2005, by Kathleen Doheny, "HealthDay" reporter
• Biopharmaceutical Companies Present Promising Data for Treating PAH, May 2005
• "Lung Fibrosis in Systemic Sclerosis", by Richard Silver, M.D., Professor of Medicine, Medical University of South Carolina (originally published in "Scleroderma Voice," 2004 Issue #1)
• Pulmonary Arterial Hypertension in Scleroderma: A New Treatment, by M. Kari Connolly, M.D., Associate Professor of Dermatology and Medicine, University of California/San Francisco (originally published in "Scleroderma Voice," 2002 #2).